National Health Investors (NYSE:NHI) Issues FY24 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided EPS guidance of $4.43-$4.44 for the period, compared to the consensus EPS estimate of $4.52. National Health Investors also updated its FY 2024 guidance to 4.430-4.440 EPS.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on NHI shares. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Bank of America started coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price on the stock. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and raised their price target for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Finally, Truist Financial upped their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a report on Friday, August 30th. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $73.29.

National Health Investors Stock Performance

Shares of NHI stock traded up $2.09 during trading on Friday, hitting $81.73. The company’s stock had a trading volume of 48,674 shares, compared to its average volume of 194,092. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. The company has a market cap of $3.55 billion, a PE ratio of 27.09, a P/E/G ratio of 5.05 and a beta of 1.05. The business has a fifty day moving average of $80.37 and a 200-day moving average of $73.21. National Health Investors has a 52 week low of $50.12 and a 52 week high of $86.13.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The company had revenue of $63.32 million during the quarter, compared to analysts’ expectations of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. National Health Investors’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same period last year, the firm posted $1.08 earnings per share. As a group, research analysts anticipate that National Health Investors will post 4.48 earnings per share for the current year.

National Health Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.90 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a yield of 4.40%. National Health Investors’s dividend payout ratio is presently 122.45%.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.